These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2157050

  • 1. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus.
    Fulton R, Plumb M, Shield L, Neil JC.
    J Virol; 1990 Apr; 64(4):1675-82. PubMed ID: 2157050
    [Abstract] [Full Text] [Related]

  • 2. Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines.
    Plumb M, Fulton R, Breimer L, Stewart M, Willison K, Neil JC.
    J Virol; 1991 Apr; 65(4):1991-9. PubMed ID: 1848314
    [Abstract] [Full Text] [Related]

  • 3. Structure and function of endogenous feline leukemia virus long terminal repeats and adjoining regions.
    Berry BT, Ghosh AK, Kumar DV, Spodick DA, Roy-Burman P.
    J Virol; 1988 Oct; 62(10):3631-41. PubMed ID: 2843665
    [Abstract] [Full Text] [Related]

  • 4. Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases.
    Matsumoto Y, Momoi Y, Watari T, Goitsuka R, Tsujimoto H, Hasegawa A.
    Virology; 1992 Aug; 189(2):745-9. PubMed ID: 1322598
    [Abstract] [Full Text] [Related]

  • 5. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
    Granger SW, Fan H.
    J Virol; 1998 Nov; 72(11):8961-70. PubMed ID: 9765441
    [Abstract] [Full Text] [Related]

  • 6. Sequence analysis of the putative viral enhancer in tissues from 33 cats with various feline leukemia virus-related diseases.
    Jackson ML, Haines DM, Misra V.
    Vet Microbiol; 1996 Dec; 53(3-4):213-25. PubMed ID: 9008333
    [Abstract] [Full Text] [Related]

  • 7. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.
    Martiney MJ, Rulli K, Beaty R, Levy LS, Lenz J.
    J Virol; 1999 Sep; 73(9):7599-606. PubMed ID: 10438850
    [Abstract] [Full Text] [Related]

  • 8. Multiple protein-binding sites in an intracisternal A particle long terminal repeat.
    Falzon M, Kuff EL.
    J Virol; 1988 Nov; 62(11):4070-7. PubMed ID: 3139894
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
    Nishigaki K, Hanson C, Thompson D, Yugawa T, Hisasue M, Tsujimoto H, Ruscetti S.
    J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
    [Abstract] [Full Text] [Related]

  • 10. Structure and function of the long terminal repeats of feline leukemia viruses derived from naturally occurring acute myeloid leukemias in cats.
    Nishigaki K, Okuda M, Endo Y, Watari T, Tsujimoto H, Hasegawa A.
    J Virol; 1997 Dec; 71(12):9823-7. PubMed ID: 9371654
    [Abstract] [Full Text] [Related]

  • 11. Carbon tetrachloride induction of rapid changes in liver nuclear protein factors capable of sequence-specific binding to regulatory elements in the long terminal repeat of polytropic-class endogenous murine leukemia virus-related proviruses.
    Hoyt PR, Wang TH, Henley DC, Yang DM, Ch'ang LY, Yang WK.
    Mol Carcinog; 1993 Dec; 8(4):245-54. PubMed ID: 8280373
    [Abstract] [Full Text] [Related]

  • 12. Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.
    Tupper JC, Chen H, Hays EF, Bristol GC, Yoshimura FK.
    J Virol; 1992 Dec; 66(12):7080-8. PubMed ID: 1331510
    [Abstract] [Full Text] [Related]

  • 13. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors.
    Athas GB, Lobelle-Rich P, Levy LS.
    J Virol; 1995 Jun; 69(6):3324-32. PubMed ID: 7745680
    [Abstract] [Full Text] [Related]

  • 14. CArG, CCAAT, and CCAAT-like protein binding sites in avian retrovirus long terminal repeat enhancers.
    Zachow KR, Conklin KF.
    J Virol; 1992 Apr; 66(4):1959-70. PubMed ID: 1312613
    [Abstract] [Full Text] [Related]

  • 15. Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors.
    Terry A, Fulton R, Stewart M, Onions DE, Neil JC.
    J Virol; 1992 Jun; 66(6):3538-49. PubMed ID: 1316466
    [Abstract] [Full Text] [Related]

  • 16. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.
    Pantginis J, Beaty RM, Levy LS, Lenz J.
    J Virol; 1997 Dec; 71(12):9786-91. PubMed ID: 9371646
    [Abstract] [Full Text] [Related]

  • 17. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
    Amtoft HW, Sørensen AB, Bareil C, Schmidt J, Luz A, Pedersen FS.
    J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
    [Abstract] [Full Text] [Related]

  • 18. Regulation of gene expression directed by the long terminal repeats of feline leukemia viruses.
    Nishigaki K, Endo Y, Matsumoto Y, Watari T, Goitsuka R, Tsujimoto H, Hasegata A.
    Leukemia; 1997 Apr; 11 Suppl 3():189-92. PubMed ID: 9209339
    [Abstract] [Full Text] [Related]

  • 19. Identification of a large bent DNA domain and binding sites for serum response factor adjacent to the NFI repeat cluster and enhancer region in the major IE94 promoter from simian cytomegalovirus.
    Chang YN, Jeang KT, Chiou CJ, Chan YJ, Pizzorno M, Hayward GS.
    J Virol; 1993 Jan; 67(1):516-29. PubMed ID: 8380090
    [Abstract] [Full Text] [Related]

  • 20. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
    Ethelberg S, Lovmand J, Schmidt J, Luz A, Pedersen FS.
    J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.